<p>Two groups with the accumulation of large (> 8.1, dotted lines) and small (≤ 8.1, solid lines) volumes of <sup>18</sup>F-FDG were determined by metabolic-tumor-volume (MTV), one of the volume-based metabolic parameters. The two groups showed significant differences in PFS (<i>p</i> = 0.03) and CSS (<i>p</i> = 0.03). Three-year PFS and CSS rates were 70% and 73% for patients with a smaller metabolic volume (MTV ≤ 8.1), and 30% and 37% for those with a larger metabolic volume (MTV > 8.1), respectively.</p
<p>Kaplan-Meier survival curve up to P 21 showing decreased survival. HC compared to NC, and improve...
<p>Patients with low-perfused gliomas had significantly longer EFS compared to patients with high-pe...
<p>The HCC patients with high Nodal expression showed notably poorer overall survival rates than tho...
Kaplan-Meier survival curves depicting relapse-free survival (RFS) according to tumor size (a), the ...
F-FDG).F-FDG, metabolic-tumor-volume (MTV) and total-lesion-glycolysis (TLG) were obtained at a thre...
<p>(<b>A</b>) The overall survival of patients who had HCC with low FLOT1 expressing tumors (bold li...
Kaplan-Meier survival curves depicting overall survival (OS) according to tumor size (a), the maximu...
<p>a) Patients with high tumor E-cadherin expression exhibit a higher probability of PFS (59.7% vs. ...
<p>Kaplan-Meier survival plots of disease-free survival according to (a) the maximum standardized up...
<p>Kaplan-Meier survival curves for localized vs. disseminated goblet cell carcinoid at diagnosis.</...
<p>Disease-specific Kaplan-Meier survival curves according to: A) PHD1, B) PHD2, C) PHD3 and D) FIH ...
<p>A and D: DFS (A) and OS (D) for TSCC and BOTSCC irrespective of the HPV status of the tumour. B a...
A positive fluorine-18 labelled 2-deoxy-2-fluoroglucose ([18F]FDG) positron emission tomography/comp...
<p>The patients were stratified into different risk groups. Two low basal (EGFR≤15% and CK5/6≤50%) r...
<p>Difference in time until progression was compared between Fok<i>I</i> C/C plus C/T and T/T.</p
<p>Kaplan-Meier survival curve up to P 21 showing decreased survival. HC compared to NC, and improve...
<p>Patients with low-perfused gliomas had significantly longer EFS compared to patients with high-pe...
<p>The HCC patients with high Nodal expression showed notably poorer overall survival rates than tho...
Kaplan-Meier survival curves depicting relapse-free survival (RFS) according to tumor size (a), the ...
F-FDG).F-FDG, metabolic-tumor-volume (MTV) and total-lesion-glycolysis (TLG) were obtained at a thre...
<p>(<b>A</b>) The overall survival of patients who had HCC with low FLOT1 expressing tumors (bold li...
Kaplan-Meier survival curves depicting overall survival (OS) according to tumor size (a), the maximu...
<p>a) Patients with high tumor E-cadherin expression exhibit a higher probability of PFS (59.7% vs. ...
<p>Kaplan-Meier survival plots of disease-free survival according to (a) the maximum standardized up...
<p>Kaplan-Meier survival curves for localized vs. disseminated goblet cell carcinoid at diagnosis.</...
<p>Disease-specific Kaplan-Meier survival curves according to: A) PHD1, B) PHD2, C) PHD3 and D) FIH ...
<p>A and D: DFS (A) and OS (D) for TSCC and BOTSCC irrespective of the HPV status of the tumour. B a...
A positive fluorine-18 labelled 2-deoxy-2-fluoroglucose ([18F]FDG) positron emission tomography/comp...
<p>The patients were stratified into different risk groups. Two low basal (EGFR≤15% and CK5/6≤50%) r...
<p>Difference in time until progression was compared between Fok<i>I</i> C/C plus C/T and T/T.</p
<p>Kaplan-Meier survival curve up to P 21 showing decreased survival. HC compared to NC, and improve...
<p>Patients with low-perfused gliomas had significantly longer EFS compared to patients with high-pe...
<p>The HCC patients with high Nodal expression showed notably poorer overall survival rates than tho...